Cancer

Cover image for Vol. 121 Issue 13

Edited By: Fadlo R. Khuri, MD

Impact Factor: 4.889

ISI Journal Citation Reports © Ranking: 2014: 32/211 (Oncology)

Online ISSN: 1097-0142

Associated Title(s): Cancer Cytopathology, CA: A Cancer Journal for Clinicians

Highlighted Papers

  • The RET oncogene in papillary thyroid carcinoma

    The RET oncogene in papillary thyroid carcinoma

    (A) Representative papillary thyroid carcinoma (PTC) cytology is observed, including prototypical nuclear crowding (yellow arrow) and nuclear clearing (red arrow; original magnification ×40). (B) Representative PTC histology reveals the papillary structure characteristic of PTC.

  • Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases

    Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases

    The study design for identifying very small nuclear circulating tumor cells (vsnCTCs) in patients with prostate cancer (PC).

  • Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry

    Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry

    Schematic of immunomagnetic enrichment coupled with flow cytometry for the detection and isolation of circulating tumor cells.

  • Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

    Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

    Hypothesis for the tubal origin of ovarian HGSC. We hypothesize that normal FTE is the cell of origin of many “ovarian” HGSCs

  • Proton therapy for low-grade gliomas: Results from a prospective trial

    Proton therapy for low-grade gliomas: Results from a prospective trial

    Dosimetric plans of proton therapy versus photon therapy for a low-grade glioma of the left temporal lobe are shown. Equivalent tumor target dose coverage is achieved but markedly less radiation is delivered to nontarget tissues with proton therapy.

  • New oral small molecules in the treatment of chronic lymphocytic leukemia

    New oral small molecules in the treatment of chronic lymphocytic leukemia

    B-cell antigen receptor (BCR) signaling in B-cell malignancies

  • Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue

    Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue

    Conceptual diagram of how the IDO pathway serves as a link between immune activation and fatigue in cancer patients.

  • Osteochondroma in long-term survivors of high-risk neuroblastoma

    Osteochondroma in long-term survivors of high-risk neuroblastoma

    Osteochondroma unrelated to radiotherapy arising from (A) the proximal ulna in a girl aged 14.4 years (patient 9) and (B) the proximal humerus in a 7.5-year-old boy (patient 11).

  • The RET oncogene in papillary thyroid carcinoma
  • Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases
  • Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry
  • Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
  • Proton therapy for low-grade gliomas: Results from a prospective trial
  • New oral small molecules in the treatment of chronic lymphocytic leukemia
  • Inflammation-induced activation of the indoleamine 2,3-dioxygenase pathway: Relevance to cancer-related fatigue
  • Osteochondroma in long-term survivors of high-risk neuroblastoma

SEARCH

SEARCH BY CITATION